Source: Human Reproduction. Conference titles: Annual Meeting of the European Society of Human Reproduction & Embryology. Unidade: FMRP
Subjects: SÍNDROME DO OVÁRIO POLICÍSTICO, DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, C. et al. Effects of oral contraceptive alone or combined with either low-dose metformin or spironolactone on cardiovascular risk markers in women with polycystic ovary syndrome. Human Reproduction. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 22 abr. 2026. , 2011APA
Vieira, C., Martins, W. P., Fernandes, J. B. F., Soares, G. M., Reis, R. M., Sá, M. F. S. de, & Ferriani, R. A. (2011). Effects of oral contraceptive alone or combined with either low-dose metformin or spironolactone on cardiovascular risk markers in women with polycystic ovary syndrome. Human Reproduction. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Vieira C, Martins WP, Fernandes JBF, Soares GM, Reis RM, Sá MFS de, Ferriani RA. Effects of oral contraceptive alone or combined with either low-dose metformin or spironolactone on cardiovascular risk markers in women with polycystic ovary syndrome. Human Reproduction. 2011 ; 26 i31.[citado 2026 abr. 22 ]Vancouver
Vieira C, Martins WP, Fernandes JBF, Soares GM, Reis RM, Sá MFS de, Ferriani RA. Effects of oral contraceptive alone or combined with either low-dose metformin or spironolactone on cardiovascular risk markers in women with polycystic ovary syndrome. Human Reproduction. 2011 ; 26 i31.[citado 2026 abr. 22 ]
